DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $20.00 by Analysts at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price cut by investment analysts at Barrington Research from $24.00 to $20.00 in a report issued on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price objective would indicate a potential upside of 19.83% from the stock’s current price.

Several other research firms also recently weighed in on XRAY. Needham & Company LLC lowered their price target on shares of DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating for the company in a research note on Friday. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Morgan Stanley reduced their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Evercore ISI reiterated an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their target price for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Ten equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $23.67.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock traded down $0.46 during trading hours on Friday, hitting $16.69. 390,201 shares of the company’s stock were exchanged, compared to its average volume of 2,405,509. The company has a market capitalization of $3.32 billion, a PE ratio of -8.03, a PEG ratio of 1.80 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 12-month low of $16.43 and a 12-month high of $34.91. The business’s 50 day simple moving average is $18.90 and its 200-day simple moving average is $21.58.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Vise Technologies Inc. purchased a new stake in DENTSPLY SIRONA in the fourth quarter worth $195,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of DENTSPLY SIRONA by 13.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier’s stock valued at $10,466,000 after buying an additional 65,308 shares in the last quarter. Voloridge Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth about $24,571,000. Tidal Investments LLC increased its stake in shares of DENTSPLY SIRONA by 15.5% in the 4th quarter. Tidal Investments LLC now owns 25,702 shares of the medical instruments supplier’s stock worth $488,000 after acquiring an additional 3,449 shares in the last quarter. Finally, True Wealth Design LLC lifted its position in DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock valued at $41,000 after acquiring an additional 1,950 shares during the period. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.